Literature DB >> 26755539

Death Associated With the Use of the Synthetic Cannabinoid ADB-FUBINACA.

Kevin G Shanks1, William Clark2, George Behonick3.   

Abstract

Synthetic cannabinoids have been found in herbal incense products for the last several years. We report the rapid death of an individual that was certified as synthetic cannabinoid-associated. The autopsy blood specimen was extracted by a liquid-liquid extraction at pH 10.2 into a hexane-ethyl acetate mixture and analyzed by a generalized synthetic cannabinoid LC-MS-MS method. For this case report, we briefly describe the instrumental analysis and extraction methods for the detection of ADB-FUBINACA in postmortem blood, toxicological results for the postmortem blood specimen (ADB-FUBINACA, 7.3 ng/mL; THC, 1.1 ng/mL; THC-COOH, 4.7 ng/mL), case information and circumstances and pertinent findings at autopsy. The cause of death was certified as coronary arterial thrombosis in combination with synthetic cannabinoid use. Manner of death was accident.
© The Author 2016. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26755539      PMCID: PMC4885918          DOI: 10.1093/jat/bkv142

Source DB:  PubMed          Journal:  J Anal Toxicol        ISSN: 0146-4760            Impact factor:   3.367


  20 in total

1.  Case reports of synthetic cannabinoid XLR-11 associated fatalities.

Authors:  Kevin G Shanks; David Winston; John Heidingsfelder; George Behonick
Journal:  Forensic Sci Int       Date:  2015-04-27       Impact factor: 2.395

2.  Schedules of controlled substances: temporary placement of three synthetic cannabinoids into schedule I. Final order.

Authors: 
Journal:  Fed Regist       Date:  2015-01-30

3.  Δ9-Tetrahydrocannabinol-like effects of novel synthetic cannabinoids found on the gray market.

Authors:  Michael B Gatch; Michael J Forster
Journal:  Behav Pharmacol       Date:  2015-08       Impact factor: 2.293

Review 4.  The endocannabinoid system and the brain.

Authors:  Raphael Mechoulam; Linda A Parker
Journal:  Annu Rev Psychol       Date:  2012-07-12       Impact factor: 24.137

5.  Schedules of controlled substances: temporary placement of four synthetic cannabinoids into Schedule I. Final order.

Authors: 
Journal:  Fed Regist       Date:  2014-02-10

6.  Four postmortem case reports with quantitative detection of the synthetic cannabinoid, 5F-PB-22.

Authors:  George Behonick; Kevin G Shanks; Dennis J Firchau; Gagan Mathur; Charles F Lynch; Marcus Nashelsky; David J Jaskierny; Chady Meroueh
Journal:  J Anal Toxicol       Date:  2014-05-29       Impact factor: 3.367

7.  UPLC/ESI-MS/MS-based determination of metabolism of several new illicit drugs, ADB-FUBINACA, AB-FUBINACA, AB-PINACA, QUPIC, 5F-QUPIC and α-PVT, by human liver microsome.

Authors:  Takahiro Takayama; Mayu Suzuki; Kenichiro Todoroki; Koichi Inoue; Jun Zhe Min; Ruri Kikura-Hanajiri; Yukihiro Goda; Toshimasa Toyo'oka
Journal:  Biomed Chromatogr       Date:  2014-06       Impact factor: 1.902

Review 8.  Pharmacology, Toxicology, and Adverse Effects of Synthetic Cannabinoid Drugs.

Authors:  S M R Gurney; K S Scott; S L Kacinko; B C Presley; B K Logan
Journal:  Forensic Sci Rev       Date:  2014-01

9.  Analysis of first and second generation legal highs for synthetic cannabinoids and synthetic stimulants by ultra-performance liquid chromatography and time of flight mass spectrometry.

Authors:  Kevin G Shanks; Tim Dahn; George Behonick; Andrea Terrell
Journal:  J Anal Toxicol       Date:  2012-05-14       Impact factor: 3.367

10.  Notes from the field: severe illness associated with reported use of synthetic marijuana - Colorado, August-September 2013.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2013-12-13       Impact factor: 17.586

View more
  16 in total

1.  The Psychoactive Surveillance Consortium and Analysis Network (PSCAN): the first year.

Authors:  Andrew A Monte; Andrew Hopkinson; Jessica Saben; Shelby K Shelton; Stephen Thornton; Aaron Schneir; Adam Pomerleau; Robert G Hendrickson; Ann M Arens; Jon B Cole; James Chenoweth; Spencer Martin; Axel Adams; Samuel D Banister; Roy R Gerona
Journal:  Addiction       Date:  2019-11-25       Impact factor: 6.526

2.  Cannabinoid-like effects of five novel carboxamide synthetic cannabinoids.

Authors:  Michael B Gatch; Michael J Forster
Journal:  Neurotoxicology       Date:  2018-11-12       Impact factor: 4.294

3.  Quantitation of Synthetic Cannabinoid Receptor Agonists in Postmortem Blood Using a Single Point Calibration.

Authors:  Phoebe Sharp; Simon Hudson; Stephen R Morley
Journal:  Acad Forensic Pathol       Date:  2021-07-20

4.  Synthetic cannabinoid "Black Mamba" infidelity in patients presenting for emergency stabilization in Colorado: a P SCAN Cohort.

Authors:  Nicklaus Brandehoff; Axel Adams; Kyle McDaniel; Samuel D Banister; Roy Gerona; Andrew A Monte
Journal:  Clin Toxicol (Phila)       Date:  2017-09-01       Impact factor: 4.467

Review 5.  What is the Current Knowledge About the Cardiovascular Risk for Users of Cannabis-Based Products? A Systematic Review.

Authors:  Emilie Jouanjus; Valentin Raymond; Maryse Lapeyre-Mestre; Valérie Wolff
Journal:  Curr Atheroscler Rep       Date:  2017-06       Impact factor: 5.113

6.  Coma, Seizures, Atrioventricular Block, and Hypoglycemia in an ADB-FUBINACA Body-Packer.

Authors:  Nicholas Nacca; Rachel Schult; Robert Loflin; Adam Weltler; Rachel Gorodetsky; Sherri Kacinko; Jeffery Moran; Alex Krotulski; Timothy Wiegand
Journal:  J Emerg Med       Date:  2018-10-05       Impact factor: 1.484

7.  In Vitro Metabolite Profiling of ADB-FUBINACA, A New Synthetic Cannabinoid.

Authors:  Jeremy Carlier; Xingxing Diao; Ariane Wohlfarth; Karl Scheidweiler; Marilyn A Huestis
Journal:  Curr Neuropharmacol       Date:  2017-07       Impact factor: 7.363

8.  Analytically Confirmed Intoxications Involving MDMB-CHMICA from the STRIDA Project.

Authors:  Matilda Bäckberg; Luiza Tworek; Olof Beck; Anders Helander
Journal:  J Med Toxicol       Date:  2016-09-16

9.  The 2-alkyl-2H-indazole regioisomers of synthetic cannabinoids AB-CHMINACA, AB-FUBINACA, AB-PINACA, and 5F-AB-PINACA are possible manufacturing impurities with cannabimimetic activities.

Authors:  Mitchell Longworth; Samuel D Banister; James B C Mack; Michelle Glass; Mark Connor; Michael Kassiou
Journal:  Forensic Toxicol       Date:  2016-04-27       Impact factor: 4.096

Review 10.  Designer drugs: mechanism of action and adverse effects.

Authors:  Dino Luethi; Matthias E Liechti
Journal:  Arch Toxicol       Date:  2020-04-06       Impact factor: 5.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.